SB 239063 is a potent, selective and orally active p38 MAPK inhibitor, exhibits an IC50 of 44 nM for recombinant purified human p38alpha, with equipotent inhibitory activity against p38alpha and p38beta. SB 239063 has no effect on p38gamma or p38delta. With anti-asthma act
Molecular Weight:
368.40
Purity:
99.61
CAS Number:
[193551-21-2]
Formula:
C20H21FN4O2
Target:
Autophagy,p38 MAPK
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted